Lung cancer care in China
Early-stage lung cancer is usually assessed for surgery first. Unresectable locally advanced lung cancer is often treated with chemoradiotherapy. For metastatic lung cancer, medicines are selected mainly according to pathology and genetic test results. Compare the options below to understand treatment cycles, hospital visits and the items included in an international department budget.
Sources (20)
- The University of Hong Kong-Shenzhen Hospital · International Medical Center consultation and bed charges (published 2025-06-04) ↗ (opens in a new window)The University of Hong Kong-Shenzhen Hospital
- Investing.com · USD/CNY historical rates (conversion uses 6.6928 on 2026-10-12) ↗ (opens in a new window)Investing.com
- National Health Commission · Guideline for diagnosis and treatment of primary lung cancer (2022): treatment, cycles and follow-up ↗ (opens in a new window)National Health Commission of China
- National Health Commission · Stage-based treatment principles in the 2024 lung cancer early diagnosis and treatment programme ↗ (opens in a new window)National Health Commission of China
- Chinese Society of Clinical Oncology · Example of conventional radiotherapy fractionation for locally advanced non-small cell lung cancer (2014) ↗ (opens in a new window)Chinese Society of Clinical Oncology
- Qinghai Cancer Hospital · Lung cancer SBRT sessions and duration (2025-09-17) ↗ (opens in a new window)Qinghai Fifth People's Hospital (Qinghai Cancer Hospital)
- HARMONi-2 · Randomised study at 55 Chinese hospitals: interim efficacy and adverse events (Lancet, 2025) ↗ (opens in a new window)Lancet/PubMed
- National Healthcare Security Administration · Osimertinib reference information and treatment duration in 2024 published application materials ↗ (opens in a new window)National Healthcare Security Administration publication / Nanjing Sanhome Pharmaceutical application
- NCI · Non-small cell lung cancer treatment and staging ↗ (opens in a new window)National Cancer Institute
- NCI · Small cell lung cancer treatment ↗ (opens in a new window)National Cancer Institute
- NCI · Biomarker testing and its limitations ↗ (opens in a new window)National Cancer Institute
- ACS · Non-small cell lung cancer treatment options and care team ↗ (opens in a new window)American Cancer Society
- ACS · Small cell lung cancer treatment options ↗ (opens in a new window)American Cancer Society
- NCI · Finding cancer care and second opinions ↗ (opens in a new window)National Cancer Institute
- NCI · Clinical trial participation, costs and safety ↗ (opens in a new window)National Cancer Institute
- NCI · Palliative care and quality of life ↗ (opens in a new window)National Cancer Institute
- NCI · Targeted therapy and side effects ↗ (opens in a new window)National Cancer Institute
- NCI · Side effects during and after immunotherapy ↗ (opens in a new window)National Cancer Institute
- NCI · Chemotherapy cycles, treatment locations, reassessment and schedule adjustments (reviewed 2025-05-15) ↗ (opens in a new window)National Cancer Institute
- ACS · Follow-up after lung cancer treatment ↗ (opens in a new window)American Cancer Society